Search - tctmd.com

Displaying 641 - 660 of 1310

Sort: Relevancy | Date

Presentation TCT 2016

Germany Presents: Treatment Options - Should Severe Mitral Regurgitation be Treated Prior, During or After TAVR (and in a Single or Staged Procedures)?

Presenter: Dariusz Dudek, Petr Kala, Holger Thiele

October 30, 2016

Presentation TCT 2016

Introduction and Session Objectives

Presenter: Dariusz Dudek, Petr Kala

October 30, 2016

Presentation TCT 2016

Bulgaria Presents: How Did I Treat This Patient?

Presenter: Michael Kang-Yin Lee, Ivo Petrov

October 30, 2016

Presentation TCT 2016

Bulgaria Presents: A Case of Left Main PCI in a Patient With ACS

Presenter: Michael Kang-Yin Lee, Ivo Petrov

October 30, 2016

Presentation TCT 2016

Valvular Heart Disease: Diagnosis and Treatment Options

Presenter: Peter Barlis, Grzegorz L. Kaluza, Nicola Corvaja

October 29, 2016

Presentation TCT 2016

Acute Coronary Syndromes: STEMI

Presenter: Peter Barlis, Grzegorz L. Kaluza, Michael C. Kim

October 29, 2016

Presentation TCT 2016

Acute Coronary Syndromes: NSTE-ACS

Presenter: Peter Barlis, Grzegorz L. Kaluza, Ziad A. Ali

October 29, 2016

Presentation TCT 2016

Bundle Payment for PCI: Are You Prepared?

Presenter: Megan Berlinger, Peter L Duffy, Duane S. Pinto

October 29, 2016

Presentation TCT 2016

Coronary Pathophysiology and FFR

Presenter: Peter Barlis, Grzegorz L. Kaluza, Allen Jeremias

October 29, 2016

Presentation TCT 2016

MACRA and Payment Changes: Are you Ready?

Presenter: Megan Berlinger, Peter L Duffy

October 29, 2016

Presentation TCT 2016

Coronary Artery Disease: Pathology and Pathogenesis

Presenter: Peter Barlis, Grzegorz L. Kaluza

October 29, 2016

Presentation TCT 2016

Cath Lab as a Value Proposition

Presenter: Megan Berlinger, Peter L Duffy, Kirk N. Garratt

October 29, 2016

Presentation TCT 2016

A Primer of Cath Lab Economics 2016

Presenter: Megan Berlinger, Peter L Duffy, Robert J. Applegate

October 29, 2016

News Features

A Dose for Doing: Healthcare Providers and Exercise Specialists Struggle With Prescribing Physical Activity

Yael L. Maxwell

October 24, 2016

News Daily News

More NOAC Comparisons See Higher Bleeding Risk With Rivaroxaban: Is the ‘Writing on the Wall’?

Shelley Wood

October 07, 2016

News Daily News

Guerra de los Medios Británicos: BMJ, Lancet Siguen Recortando el Uso de Estatinas

Todd Neale

September 19, 2016

News Daily News

La Endocarditis Infecciosa Post-TAVR se asocia a Diabetes, Regurgitación Aórtica Residual en un Extenso Registro

Yael L. Maxwell

September 14, 2016

News Daily News

Infective Endocarditis After TAVR Linked to Diabetes, Residual Aortic Regurgitation in Large Registry

Yael L. Maxwell

September 14, 2016

News Conference News ESC 2016

Optimal Approach for BP Lowering Debated Amid New J-Curve Signals in Stable CAD

Todd Neale

September 09, 2016

News Opinion Editor's Corner ESC 2016

My Takeaways From ESC 2016: Eye-Rolling, Disappointments, and a Sobering Comeuppance

Shelley Wood

September 08, 2016

Advertisement

Germany Presents: Treatment Options - Should Severe Mitral Regurgitation be Treated Prior, During or After TAVR (and in a Single or Staged Procedures)?

Introduction and Session Objectives

Bulgaria Presents: How Did I Treat This Patient?

Bulgaria Presents: A Case of Left Main PCI in a Patient With ACS

Valvular Heart Disease: Diagnosis and Treatment Options

Acute Coronary Syndromes: STEMI

Acute Coronary Syndromes: NSTE-ACS

Bundle Payment for PCI: Are You Prepared?

Coronary Pathophysiology and FFR

MACRA and Payment Changes: Are you Ready?

Coronary Artery Disease: Pathology and Pathogenesis

Cath Lab as a Value Proposition

A Primer of Cath Lab Economics 2016

A Dose for Doing: Healthcare Providers and Exercise Specialists Struggle With Prescribing Physical Activity

More NOAC Comparisons See Higher Bleeding Risk With Rivaroxaban: Is the ‘Writing on the Wall’?

Guerra de los Medios Británicos: BMJ, Lancet Siguen Recortando el Uso de Estatinas

La Endocarditis Infecciosa Post-TAVR se asocia a Diabetes, Regurgitación Aórtica Residual en un Extenso Registro

Infective Endocarditis After TAVR Linked to Diabetes, Residual Aortic Regurgitation in Large Registry

Optimal Approach for BP Lowering Debated Amid New J-Curve Signals in Stable CAD

My Takeaways From ESC 2016: Eye-Rolling, Disappointments, and a Sobering Comeuppance

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content